Several RBPs have been studied for their correlation between chemoresistance and aberrant expressions, such as the higher expression of Lin28 in gastric, breast, and colon cancer (Lv et al., 2012; Teng et al., 2015), and others. This evidence concerns the gene LIN28A and malignant colon neoplasm.